SERA PROGNOSTICS, INC. Shareholders' Equity
SERA PROGNOSTICS, INC. (SERA) had Shareholders' Equity of $59.38 million as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Balance Sheet › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-12
- 2026-06-30: Stockholders' Equity Attributable to Parent $59.38M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $67.62M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $75.41M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $82.18M.
| Period end | Stockholders' Equity Attributable to Parent |
|---|---|
| 2026-06-30 | $59.38M 10-Q · filed 2026-08-12 |
| 2026-03-31 | $67.62M 10-Q · filed 2026-08-12 |
| 2025-12-31 | $75.41M 10-Q · filed 2026-08-12 |
| 2025-09-30 | $82.18M 10-Q · filed 2025-11-13 |
| 2025-06-30 | $88.23M 10-Q · filed 2026-08-12 |
| 2025-03-31 | $94.78M 10-Q · filed 2026-08-12 |
| 2024-12-31 | $47.80M 10-Q · filed 2026-08-12 |
| 2024-09-30 | $54.65M 10-Q · filed 2025-11-13 |
| 2024-06-30 | $59.75M 10-Q · filed 2025-11-13 |
| 2024-03-31 | $64.75M 10-Q · filed 2025-11-13 |
| 2023-12-31 | $70.16M 10-K · filed 2026-03-18 |
| 2023-09-30 | $75.41M 10-Q · filed 2024-11-06 |
| 2023-06-30 | $81.14M 10-Q · filed 2024-11-06 |
| 2023-03-31 | $90.21M 10-Q · filed 2024-11-06 |
| 2022-12-31 | $98.94M 10-K · filed 2025-03-19 |
| 2022-09-30 | $107.16M 10-Q · filed 2023-11-08 |
| 2022-06-30 | $116.91M 10-Q · filed 2023-11-08 |
| 2022-03-31 | $127.20M 10-Q · filed 2023-11-08 |
| 2021-12-31 | $138.56M 10-K · filed 2024-03-20 |
| 2021-09-30 | $150.04M 10-Q · filed 2022-11-09 |
| 2021-06-30 | -$135.80M 10-Q · filed 2022-11-09 |
| 2021-03-31 | -$130.39M 10-Q · filed 2022-11-09 |
| 2020-12-31 | -$125.57M 10-K · filed 2023-03-22 |
| 2020-09-30 | -$120.49M 10-Q · filed 2021-11-09 |
| 2020-06-30 | -$115.69M 10-Q · filed 2021-11-09 |
| 2020-03-31 | -$111.18M 10-Q · filed 2021-11-09 |
| 2019-12-31 | -$106.62M 10-K · filed 2022-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |